LEVOXYL® Principal Display Panel (levothyroxine sodium)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 25 mcg Tablet Bottle Label

NDC 60793-850-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

25 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 50 mcg Tablet Bottle Label

NDC 60793-851-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

50 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 75 mcg Tablet Bottle Label

NDC 60793-852-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

75 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 88 mcg Tablet Bottle Label

NDC 60793-853-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

88 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 100 mcg Tablet Bottle Label

NDC 60793-854-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

100 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 112 mcg Tablet Bottle Label

NDC 60793-855-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

112 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 125 mcg Tablet Bottle Label

NDC 60793-856-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

125 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 137 mcg Tablet Bottle Label

NDC 60793-857-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

137 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 150 mcg Tablet Bottle Label

NDC 60793-858-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

150 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 175 mcg Tablet Bottle Label

NDC 60793-859-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

175 mcg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 200 mcg Tablet Bottle Label

NDC 60793-860-01

Pfizer

Levoxyl®
(levothyroxine
sodium tablets, USP)
tablets

200 mcg

100 Tablets
Rx only

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

LEVOXYL® Quick Finder

Ingredient & Allergen Checker
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All